Schizophrenia and Disorders with Psychotic Features  >>  Doria (risperidone extended release)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Doria (risperidone extended release) / ROVI Pharmaceuticals Laboratories
PRISMA-1, NCT01788774: Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISMĀ® at Different Dose Strengths

Completed
1
36
Europe, RoW
Risperidone ISM 50 mg, Risperidone ISM 75 mg, Risperidone ISM 100 mg
Rovi Pharmaceuticals Laboratories
Schizophrenia, Schizoaffective Disorder
02/14
02/14

Download Options